News & Updates

Show Multimedia Only

Patients with MASLD face heightened diabetes risk

14 Jul 2026 by

Metabolic dysfunction-associated steatotic liver disease (MASLD) carries an increased risk of type 2 diabetes (T2D), with the risk increase disproportionately higher for individuals with earlier-onset MASLD, as shown in a study.

Patients with MASLD face heightened diabetes risk

14 Jul 2026

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

14 Jul 2026

Offering low-sweet snacks and caregiver education can help reduce daily added sugar and sugar-sweetened beverage (SSB) intakes among children and their caregivers, according to a study.

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

14 Jul 2026

AI-supported digital microscopy improves lab diagnostics in primary healthcare

14 Jul 2026 by

Digital microscopy combined with artificial intelligence (AI) demonstrates comparable accuracy to the reference standard for identifying multiple targets in primary healthcare laboratories and may even increase sensitivity in diagnosis, reports a study.

AI-supported digital microscopy improves lab diagnostics in primary healthcare

14 Jul 2026

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

14 Jul 2026

Daily intake of calcium-enriched permeate (CP) supplement in two doses is comparably effective as taking calcium carbonate (CC) in suppressing bone turnover markers and maintaining bone mineral density (BMD) in postmenopausal women with vitamin D sufficiency, reveals a study, noting that inulin offers no additional advantage.

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

14 Jul 2026

Is whole goat milk formula protective against AD in infants?

14 Jul 2026 by

Results from the GIraFFE* study shed light on the potential protective effect of whole goat milk formula (WGF) against the development of atopic dermatitis (AD) in infants, compared with cow milk formula (CF).

Is whole goat milk formula protective against AD in infants?

14 Jul 2026

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

14 Jul 2026

Treatment with the combination of cagrilintide plus semaglutide is safe and efficacious for lowering glycaemic levels in individuals with early-stage type 2 diabetes inadequately controlled with diet and exercise, as shown in the phase IIIa REIMAGINE 1 trial.

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

14 Jul 2026

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

14 Jul 2026 by

Treatment with nipocalimab significantly improves haemoglobin (Hgb) levels as early as week 1, with effects persisting through week 24 in patients with warm autoimmune haemolytic anaemia (wAIHA), according to the phase II/III ENERGY trial presented at EHA 2026.

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

14 Jul 2026

JoyAge programme reduces depressive and anxiety symptoms and loneliness in older adults

14 Jul 2026 by

JoyAge, an integrated prevention programme, effectively reduces symptoms of depression and anxiety as well as loneliness in older adults in Hong Kong, a pragmatic quasi-experimental trial has shown.

JoyAge programme reduces depressive and anxiety symptoms and loneliness in older adults

14 Jul 2026

Topical ivermectin, encapsulated benzoyl peroxide come first among rosacea medications

13 Jul 2026 by

Topical ivermectin and encapsulated benzoyl peroxide demonstrate superior short-term efficacy compared with metronidazole in the treatment of adults with moderate-to-severe rosacea in a network meta-analysis, although encapsulated benzoyl peroxide is also associated with higher treatment discontinuation rates due to adverse events.

Topical ivermectin, encapsulated benzoyl peroxide come first among rosacea medications

13 Jul 2026

SGLT2 inhibitor use helps reduce cardiovascular, renal deaths

13 Jul 2026

Patients with diabetes mellitus, heart failure, or chronic kidney disease treated with sodium glucose co-transporter-2 inhibitors (SGLT2i) have a reduced risk of mortality from cardiovascular and renal causes, according to a study.

SGLT2 inhibitor use helps reduce cardiovascular, renal deaths

13 Jul 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Patients with MASLD face heightened diabetes risk

Patients with MASLD face heightened diabetes risk

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

Eating low-sweet snacks, caregiver education reduce children’s sugar intake

AI-supported digital microscopy improves lab diagnostics in primary healthcare

AI-supported digital microscopy improves lab diagnostics in primary healthcare

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

Calcium-enriched permeate supplement prevents bone loss in postmenopausal women

Is whole goat milk formula protective against AD in infants?

Is whole goat milk formula protective against AD in infants?

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

Nipocalimab shows rapid, durable Hgb improvement in adults with wAIHA

JoyAge programme reduces depressive and anxiety symptoms and loneliness in older adults

JoyAge programme reduces depressive and anxiety symptoms and loneliness in older adults

Topical ivermectin, encapsulated benzoyl peroxide come first among rosacea medications

Topical ivermectin, encapsulated benzoyl peroxide come first among rosacea medications

SGLT2 inhibitor use helps reduce cardiovascular, renal deaths

SGLT2 inhibitor use helps reduce cardiovascular, renal deaths